<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>News Vulture &#187; TB</title>
	<atom:link href="http://www.newsvulture.com/tag/tb/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newsvulture.com</link>
	<description>Focusing on Corruption in India. Bringing out the profiles most crooked in India.</description>
	<lastBuildDate>Wed, 08 Jun 2011 21:32:55 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>TB enzyme decoded to develop new drugs</title>
		<link>http://www.newsvulture.com/2009/03/29/tb-enzyme-decoded-to-develop-new-drugs/</link>
		<comments>http://www.newsvulture.com/2009/03/29/tb-enzyme-decoded-to-develop-new-drugs/#comments</comments>
		<pubDate>Sun, 29 Mar 2009 10:22:14 +0000</pubDate>
		<dc:creator>Sunbird</dc:creator>
				<category><![CDATA[Science]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[TB drug]]></category>
		<category><![CDATA[Tuberculosis]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newsvulture.com/?p=326</guid>
		<description><![CDATA[Scientists have decoded the unique structure and mechanism of a tuberculosis enzyme, paving way for development of new drugs to combat active and latent tuberculosis infections. Barbara Gerratana, assistant chemistry and biochemistry professor in Maryland University College of Chemical and Life Sciences, led the research team, which included her graduate student Melissa Resto and assistant professor Nicole LaRonde-LeBlanc. &#8220;The NAD plus synthetase enzyme that our study describes is absolutely essential for the survival of tuberculosis bacteria and an important drug target. We can now use the information we have about its structure and mechanism to develop inhibitors for this enzyme,&#8221; Gerratana explained. The development of new TB drugs has become urgent, as strains of TB resistant to all major anti-TB drugs have emerged worldwide. World Health Organisation estimates that one-third of the world&#8217;s population carries latent TB and that 10 percent will eventually develop the disease, said a Maryland release.]]></description>
		<wfw:commentRss>http://www.newsvulture.com/2009/03/29/tb-enzyme-decoded-to-develop-new-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More funds for TB Research</title>
		<link>http://www.newsvulture.com/2009/03/24/more-funds-for-tb-research/</link>
		<comments>http://www.newsvulture.com/2009/03/24/more-funds-for-tb-research/#comments</comments>
		<pubDate>Tue, 24 Mar 2009 09:39:50 +0000</pubDate>
		<dc:creator>Sunbird</dc:creator>
				<category><![CDATA[Science]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[drug resistance]]></category>
		<category><![CDATA[new strains]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[Tuberculosis]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[World health Organization]]></category>

		<guid isPermaLink="false">http://www.newsvulture.com/?p=258</guid>
		<description><![CDATA[The World Health Organization says more money and better science are urgently needed to rein in new, drug-resistant strains of tuberculosis. While TB has been around for a long time and the basic form is treatable, the WHO says the disease still kills more than 1.5 million people every year. About 9 million people are infected, most of them in Africa and Asia. The WHO released its annual report on the disease in China today, and its TB program coordinator in that country says while new drug resistant strains are a growing threat, their spread can be prevented if more is spent on control programs. Drug-resistance develops when patients are not treated properly or interrupt their treatment after they start feeling better. That gives bacteria an opportunity to develop a defense against the medicines. Dr. Cornelia Hennig says better medical tests and new, more effective drugs also need to be developed. She says, right now, the worst strains are virtually untreatable.]]></description>
		<wfw:commentRss>http://www.newsvulture.com/2009/03/24/more-funds-for-tb-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

